Exercise for Parkinson's Disease: What Does the Evidence Show?

Around 166,000 people in the UK are living with Parkinson’s disease — and someone receives a new diagnosis approximately every 20 minutes (Parkinson’s UK, 2025). Most people in that position know, at some level, that staying active is advisable. What few understand is what the clinical evidence actually shows: the scale of it, the nuance of it, and what it means to apply it safely at a specific stage of the disease.

This piece sets out what the research confirms, where its limits are, and what a clinical approach to exercise for Parkinson’s actually involves — drawing on peer-reviewed evidence and the clinical framework used at Vitruvian Exercise Physiology in London.

TL;DR: Around 166,000 people in the UK are living with Parkinson’s disease, and a 2023 Cochrane review of 156 studies confirms that regular physical activity offers meaningful benefits for both movement and cognitive symptoms. The clinical consensus is that exercise works best as part of an individualised approach alongside medication - not as a replacement for it. Evidence supports a minimum of 2.5 hours of physical activity per week, tailored to the individual’s stage of disease and capability. (Sources: Parkinson’s UK 2025; Cochrane Library 2023)

What Role Does Exercise Play in Parkinson’s Disease Management?

Exercise is recognised as an adjunct treatment for Parkinson’s disease, meaning it works alongside, not instead of, an individualised medication regimen. Research demonstrates significant benefits for both movement and cognitive symptoms, making it one of the most evidence-supported non-pharmacological interventions available. Current best practice involves a medication regimen supplemented with physical activity and exercise to assist with Parkinson’s disease-related symptoms, enhance quality of life, and help maintain independence.

The word “adjunct” is clinically precise, and it matters for anyone navigating a new diagnosis. Exercise does not replace medication. Medication does not make exercise unnecessary. The two work together - each contributing something the other cannot.

Parkinson’s UK states that physical activity can be as important as getting the right medication dose for managing day-to-day symptoms. That’s a significant endorsement, and it reflects the growing body of research that has accumulated over the past decade. For a carer supporting a family member, or a person newly diagnosed, exploring what’s available beyond pharmacological management, understanding this relationship clearly is a useful starting point.

Research demonstrates significant benefits for both movement and cognitive symptoms. The distinction matters because Parkinson’s is often understood primarily as a movement disorder, when in fact its effects extend considerably beyond motor function. A clinical approach takes both dimensions into account from the outset.

For more information about our Parkinson's exercise services, visit this page.

What Does the Research Evidence Actually Show?

The evidence base for exercise in Parkinson’s disease is substantial and continues to grow. A 2023 Cochrane systematic review - the highest standard of evidence synthesis in medicine - included 156 studies involving 7,939 participants, and found beneficial effects across multiple exercise types compared to no exercise (Cochrane Library, 2023). The scale of this is significant: it is not one study, not a case series, not an anecdote. It is the pooled analysis of more than 150 independent research programmes.

Motor symptoms - the tremors, stiffness, and movement difficulties most closely associated with Parkinson’s - showed measurable improvement across the evidence base. A 2023 meta-analysis published in PMC found statistically significant improvements in motor function, with an effect size (Hedges’ g) of −0.39, indicating meaningful clinical benefit. Gait velocity, balance, and the ability to perform daily physical tasks all showed positive effects.

One of the more striking findings from the longitudinal literature concerns the longer-term relationship between physical activity and functional decline. A five-year study of 237 people with early Parkinson’s disease found that those who maintained regular physical activity showed a slower decline in their ability to perform activities of daily living than those who were less active (Neurology, 2022). This is not the same as saying exercise slows the disease itself - the researchers are careful about that distinction - but slower functional decline over five years is clinically meaningful to anyone living with the condition.

The Cochrane reviewers note that the certainty of evidence varies: for some outcomes, it is rated as low to very low, reflecting the genuine methodological challenges of conducting exercise trials in this population. That honesty is worth holding onto. The evidence for exercise in Parkinson’s is strong, but researchers are still refining their understanding of which approaches produce which outcomes, in which patient groups, at which stages of the disease.

Area	Evidence Strength	Key Source
Motor symptoms (tremor, rigidity, gait)	Strong	Cochrane 2023; PMC meta-analysis 2023
Balance and fall prevention	Strong	Cochrane 2023
Cognitive function	Moderate	Frontiers in Cognition 2024
Non-motor symptoms (mood, anxiety)	Moderate	2024 systematic review
Quality of life	Emerging	2024 systematic review

Figure 1: Areas where exercise research shows consistent benefits in Parkinson’s disease — synthesised from Cochrane Library 2023, PMC 2023, Frontiers in Cognition 2024

How Much Physical Activity Does the Evidence Support?

Evidence supports a minimum of 2.5 hours of physical activity per week for people with Parkinson’s disease - a figure endorsed by Parkinson’s UK and reflected in clinical guidance at Vitruvian Exercise Physiology (Parkinson’s UK, 2025). But the number alone tells only part of the story.

What counts toward that 2.5 hours, how it’s structured, and what intensity is appropriate all depend on where an individual is in their disease progression and on their current capabilities. Someone in the early stages of Parkinson’s has a different clinical profile from someone who has been living with the condition for a decade. The same volume of activity means something entirely different in each case.

This is where the distinction between general public health guidance and a clinically individualised approach becomes relevant. Public guidance can offer a number. Clinical exercise physiology starts with a detailed assessment of the individual, their disease stage, current physical capacity, goals, and any precautions that apply, and builds from there.

In clinical practice with people living with Parkinson’s in London, the 2.5-hour guideline is rarely the barrier in itself. What people most often benefit from is support in understanding what physical activity looks like at their stage, confidence to engage with it safely, and a programme that can adapt as their condition evolves. The number matters less than what it means for this person, right now.

The 2.5-hour benchmark is the evidence-supported floor, the minimum associated with meaningful benefit. What lies above that minimum and how it is reached are clinical questions specific to each individual. For example, as exercise physiologists, we often explore the link between frailty and exercise.

Why Does an Individualised Approach Matter?

Parkinson’s disease does not present uniformly, and it doesn’t progress at the same pace in every individual. An exercise approach appropriate for someone newly diagnosed may be entirely different from what supports someone who has been living with the condition for several years. This is why clinical exercise physiology, which begins with a detailed individual assessment, offers something that generic exercise guidance cannot.

A clinical exercise physiologist working with someone with Parkinson’s is not delivering a standardised programme. They’re beginning with a careful understanding of where that individual is: their current motor and cognitive function, their history of physical activity, any fall risk, any comorbidities, their energy levels, and their goals. From that assessment, a programme is designed that is appropriate for this person at this stage, given these capabilities.

The difference between this and general advice to “be more active” is not trivial. It concerns safety, specificity, and sustainability. Generic advice carries no accountability for individual variation. A clinical programme is built precisely on that variation.

For someone with significant motor difficulties or transport constraints, a home visit or remote session removes a barrier that would otherwise prevent engagement. The format of the session is a clinical consideration, not just a convenience.

Vitruvian Exercise Physiology offers clinical exercise physiology services for Parkinson’s disease, with sessions available at home, in a gym, or remotely. The flexibility of format reflects the clinical reality: for many people with Parkinson’s, the logistics of attending a fixed location regularly are themselves a barrier to consistent engagement.

Beyond Movement - What About Cognitive and Emotional Symptoms?

Research demonstrates significant benefits for “both movement and cognitive symptoms” in Parkinson’s disease, a distinction worth dwelling on. Parkinson’s is formally classified as a movement disorder, but its cognitive and emotional dimensions are significant and often underemphasised in much patient-facing content. This is increasingly well-supported by the evidence.

Mild cognitive impairment affects an estimated 20–50% of people with Parkinson’s disease (Frontiers in Cognition, 2024). This can include difficulties with memory, attention, and executive function. For those affected, the cognitive dimension of Parkinson’s can be as disruptive to daily life as the motor symptoms - sometimes more so. It shapes how people manage medication, navigate social situations, and plan their days.

Research has found that regular physical activity can support cognitive function and help manage non-motor symptoms, including anxiety and depression. In a 2024 systematic review, nine studies demonstrated significant improvement in motor symptoms, and seven showed significant improvement in non-motor symptoms. Seven out of fifteen studies also found significant improvements in quality of life.

The cognitive and non-motor benefit angle represents a genuine gap in how exercise for Parkinson’s is typically discussed. Most patient-facing content focuses almost entirely on the motor dimension - tremors, gait, rigidity. For the significant proportion of people with Parkinson’s managing cognitive difficulties or mood changes, the evidence that physical activity can help with those outcomes, too, is rarely surfaced clearly. It should be.

Outcome	Studies Showing Significant Improvement	Total Studies
Motor symptoms	9	15
Non-motor symptoms (mood, anxiety)	7	15
Quality of life	7	15

Figure 2: Outcomes showing significant improvement in the 2024 systematic review of exercise interventions in Parkinson’s disease

According to the Vitruvian Parkinson’s clinical framework, the research demonstrates significant benefits for both movement and cognitive symptoms, and a programme designed to address both dimensions will deliver more for someone’s overall quality of life than one focused on movement alone.

The Challenges of Getting Started and Staying Consistent

Despite the evidence, exercising consistently with Parkinson’s disease is genuinely difficult, and it’s worth being honest about that. Research published in the Journal of Parkinson’s Disease (2024) found that time constraints and family obligations were cited as adherence barriers in more than 44% of the studies reviewed. Motor symptoms create a particular challenge: the very difficulties that make exercise important also make it harder to initiate and maintain.

Fear of falling, fatigue, reduced confidence, and the fluctuating nature of Parkinson’s symptoms across the day can all affect someone’s ability to engage consistently. Pain, whether Parkinson’s-related or from musculoskeletal conditions that often coexist with it, is another common barrier. These aren’t reasons to avoid physical activity; rather, they explain why unsupported, self-directed activity is hard to sustain and why professional clinical support tends to make a practical difference to adherence.

Research consistently shows that supervised exercise programmes produce better adherence than self-directed activity, not because people with Parkinson’s lack motivation, but because clinical and practical support addresses the specific barriers as they arise, rather than leaving the individual to manage them alone.

For people with Parkinson’s who find regular travel difficult, remote session options offer a practical alternative that removes a significant logistical barrier. What matters most is that the activity happens consistently, and that the programme is designed to make that as sustainable as possible.

What Does Clinical Exercise Physiology for Parkinson’s Involve at Vitruvian?

Vitruvian Exercise Physiology offers clinical exercise physiology for Parkinson’s disease in London (W8 - Kensington), with sessions available at home, in a gym setting, or remotely. The starting point is always an individual assessment, not a generic programme.

Our practitioners at Vitruvian hold accreditation from AHCS (Academy for Healthcare Science) and ESSA (Exercise and Sports Science Australia), professional body's for clinical exercise physiologists. This indicates a practitioner who has met the training and professional standards required to work with people managing long-term health conditions, including neurological conditions such as Parkinson’s disease.

The clinical approach aligns with current best practice: an individualised programme, designed around the individual’s disease stage and current capabilities, that works alongside - not instead of - an existing medication regime. Assessment comes first. The programme follows. And it is designed to adapt as the condition changes, because Parkinson’s disease does not remain static.

Vitruvian was founded in 2018 and works with a range of clinical conditions, including Parkinson’s disease, cancer, osteoporosis, sarcopenia, and osteoarthritis. The breadth of clinical scope reflects the competency required to work safely with a complex, comorbid patient population, and to understand how conditions like Parkinson’s interact with other aspects of someone’s health.

If you or someone you care for is living with Parkinson’s disease and would like to understand what clinical exercise physiology can offer, we offer consultations at our London (W8) practice, with home visits and remote options also available. If you'd like more information, please contact us.

Frequently Asked Questions

How does exercise help Parkinson’s disease?

Exercise is recognised as an adjunct treatment for Parkinson’s disease — working alongside an individualised medication regime rather than replacing it. A 2023 Cochrane systematic review of 156 studies involving 7,939 participants confirmed significant benefits for both movement and cognitive symptoms. Research shows measurable improvements in motor function, balance, gait, cognitive function, and quality of life compared to no exercise. (Cochrane Library, 2023)

How much exercise should someone with Parkinson’s disease do?

Evidence supports a minimum of 2.5 hours of physical activity per week — a figure endorsed by Parkinson’s UK and reflected in clinical practice at Vitruvian Exercise Physiology. The right amount and structure will vary based on the individual’s current disease stage and capabilities, which is why individual clinical assessment matters before starting or significantly changing activity levels. (Parkinson’s UK, 2025)

Can exercise slow the progression of Parkinson’s disease?

A five-year longitudinal study of 237 people with early Parkinson’s disease found that those who maintained regular physical activity showed a slower decline in their ability to perform activities of daily living than less active individuals (Neurology, 2022). Researchers note that larger standardised trials are still needed before definitive claims about disease modification can be made - but the findings of functional decline over five years are clinically meaningful.

What are the cognitive benefits of exercise for Parkinson’s disease?

Mild cognitive impairment affects an estimated 20–50% of people with Parkinson’s disease (Frontiers in Cognition, 2024). Research has found that regular physical activity can support cognitive function and help manage non-motor symptoms, including anxiety and depression. A 2024 systematic review found that seven of fifteen studies showed significant improvement in non-motor symptoms across the reviewed exercise interventions.

Is clinical exercise physiology different from physiotherapy for Parkinson’s?

Yes. Clinical exercise physiologists specialise in exercise as a therapeutic tool for the long-term management of health conditions, including neurological conditions like Parkinson’s disease. Where physiotherapy often focuses on rehabilitation following specific events or episodes, clinical exercise physiology centres on ongoing condition management through a tailored physical activity programme — designed around an individual’s stage of disease, current capabilities, and personal goals.

Key Takeaways

• The evidence for exercise in Parkinson’s disease is substantial: a 2023 Cochrane review of 156 studies confirms significant benefits for motor symptoms, cognitive function, and quality of life.

• Exercise works as an adjunct treatment alongside medication - not as an alternative to it. The clinical consensus is clear on this distinction.

• The evidence-supported minimum is 2.5 hours of physical activity per week, but what that means in practice depends entirely on the individual’s disease stage and current capabilities.

• An individualised, assessment-first clinical approach offers something generic exercise advice cannot: a programme that is safe, specific, and responsive to how Parkinson’s actually affects this person, right now.

• Beyond motor symptoms, the cognitive and non-motor benefits of exercise in Parkinson’s disease are well-evidenced and underemphasised - significant improvements in mood, anxiety, and quality of life have been found across multiple studies.

If you or someone you care for is living with Parkinson’s disease and would like to understand what clinical exercise physiology can offer, contact Vitruvian Exercise Physiology for a consultation in London (W8), with home visit and remote options also available.

---

Matt Butterworth is a clinical exercise physiologist and founder of Vitruvian Exercise Physiology. He holds AHCS and ESSA accreditation and works with people living with neurological, musculoskeletal, cancer and metabolic conditions, at the practice’s London (W8) base and via home visits and remote appointments. Vitruvian Exercise Physiology has been in practice since 2018.

Sources: Parkinson’s UK (2025) · Cochrane Library (2023) · PMC meta-analysis (2023) · Neurology journal (2022) · Frontiers in Cognition (2024) · Journal of Parkinson’s Disease (2024) · 2024 systematic review of exercise interventions in Parkinson’s disease